Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Alzheimer's disease

Recent news which mentions Alzheimer's disease

< Previous 1 2 3 4 Next >
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
Tags US Economy Health & Science Politics
From CNBC.com News
Medicare details plan to cover Alzheimer's treatments
Tags U/S/ Economy US: News Biotechnology
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags Eisai Co Ltd Politics Eli Lilly and Co
From CNBC.com News
FDA commissioner praises Eli Lilly Alzheimer's treatment results
Tags Breaking News: Business Health care industry Biotechnology
From CNBC.com News
Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial
Tags Business Eli Lilly and Co Politics
From CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
Tags Pharmaceuticals US: News Business News
From CNBC.com News
March 2023 Miscellany
Tags Cancer Alzheimer's Disease Eisai (ESALY)
From Stock Gumshoe
Getting Back to You on Anavex, Cassava, metformin and more
Tags Eisai (ESALY) NervGen Pharma (NGEN/V NGENF) metformin
From Stock Gumshoe
Relevant Updates – December 2022
Tags Doc Gumshoe Lexeo Therapeutics Biogen Idec (BIIB)
From Stock Gumshoe
Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months
Tickers MOR RHHBF RHHBY RHHVF
Tags General Movers Large Cap
From Benzinga
A brain expert shares his 7 'hard rules' for boosting memory and fighting off dementia
Tags Alzheimer's disease Dementia Make It / Life
From CNBC.com News
Study Shows Positive Results In Patients With Alzheimer's Disease And Agitation
Tickers SPRC
Tags Benzinga Health Care Alzheimer's disease
From Benzinga
Odd & Ends – October 2022
Tags Roche (RHHBF RHHBY) Doc Gumshoe Eli Lilly (LLY)
From Stock Gumshoe
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
Tickers ABOS ACIU ALZN ANVS
Tags Movers NVO CGTX
From Benzinga
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
Tickers BIIB ESALY
Tags Marc Goodman lecanemab SVB Leerink
From Benzinga
Following Up on Your Suggestions – September 2022
Tickers DIET
Tags inflammation Rheumatoid Arthritis Doc Gumshoe
From Stock Gumshoe
Alzheimer's Disease: A New Generation of Screenings and Therapies on the Horizon
Tickers DGX
Tags Dr Pat Alagia Events, Media & Communications Health & Healthcare
From 3BL Media: Corporate Social Responsibility, Energy and Health News
EXCLUSIVE: Cognition Therapeutics Shares Biomarker Data From Alzheimer's Candidate
Tickers CGTX
Tags General Penny Stocks CGTX
From Benzinga
Alzheimer’s Drug Development — July Responses to Questions & Requests
Tags INmune Bio (INMB) Alzheimer's Disease Doc Gumshoe
From Stock Gumshoe
AbbVie Dumps An Early-Alzheimer's Candidate Developing In Collaboration With Alector
Tickers ABBV ALEC
Tags General Small Cap ABBV
From Benzinga
Alzheimer’s Disease June 2022 – Possible Signs of Progress
Tags Alzheimer's Disease Cassava Sciences (SAVA) TauRX Pharmaceuticals
From Stock Gumshoe
Researchers Investigate New Treatment Pathways For Alzheimer's After Commercial Failure Of Biogen's Aduhelm
Tickers BIIB
Tags General Aduhelm BIIB
From Benzinga
Alzheimer’s Disease May 2022 – Is There Anything New?
Tags Biogen Idec (BIIB) Doc Gumshoe Alzheimer's Disease
From Stock Gumshoe
Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
Tickers BIIB ESALF ESALY
Tags BIIB ESALY News
From Benzinga
New York Times Report Fresh Allegations On Cassava's Simufilam Alzheimer's Trials, Shares Fall
Tickers SAVA
Tags Small Cap Market News Health Care
From Benzinga
EXCLUSIVE: Longeveron Adds Miami Veterans Affairs Site To Its Ongoing Mid-Stage Alzheimer's Trial
Tickers LGVN
Tags Phase 2 Trial LGVN Market News
From Benzinga
Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
Tickers BIIB
Tags Alzheimer’s Benzinga Biotech
From Benzinga
EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal
Tickers LGVN
Tags News Alzheimer’s Alzheimer's disease
From Benzinga
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
Tickers BIIB ESALF ESALY
Tags General ESALY BIIB
From Benzinga
Biogen Shares Aduhelm Data In Alzheimer's Disease At 128 Weeks
Tickers BIIB
Tags Market News BIIB Alzheimer's disease
From Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.